10x Genomics: Q4 Earnings Insights

10x Genomics TXG reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

10x Genomics beat estimated earnings by 33.33%, reporting an EPS of $-0.24 versus an estimate of $-0.36.

Revenue was up $27.75 million from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 8.73% increase in the share price the next day.

Here's a look at 10x Genomics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.46	-0.39	-0.37	-0.31
EPS Actual	-0.44	-0.53	-0.44	-0.15
Revenue Estimate	151.26M	138.97M	128.82M	148.69M
Revenue Actual	153.64M	146.82M	134.28M	156.23M

To track all earnings releases for 10x Genomics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar